tiprankstipranks
Trending News
More News >
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF
US Market
Advertisement

Neuren Pharmaceuticals Limited (NURPF) Ratios

Compare
54 Followers

Neuren Pharmaceuticals Limited Ratios

NURPF's free cash flow for Q2 2025 was AU$0.47. For the 2025 fiscal year, NURPF's free cash flow was decreased by AU$ and operating cash flow was AU$0.39. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.73 5.78 25.77 49.87 33.12
Quick Ratio
8.73 5.78 25.77 49.87 34.13
Cash Ratio
0.07 0.40 23.95 45.81 32.12
Solvency Ratio
3.10 3.67 0.12 -9.70 -12.20
Operating Cash Flow Ratio
-0.25 4.32 2.14 -12.42 -10.73
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 312.27MAU$ 204.39MAU$ 41.57MAU$ 39.24MAU$ 24.19M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.13 1.21 1.04 1.02 1.03
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
-0.03 -0.09 25.33 4.47 2.75
Profitability Margins
Gross Profit Margin
84.79%88.47%99.93%99.75%99.16%
EBIT Margin
82.63%85.89%-11.04%-343.79%-1382.15%
EBITDA Margin
82.64%85.92%-10.90%-257.27%-1227.75%
Operating Profit Margin
67.42%74.37%-10.97%-357.52%-1328.59%
Pretax Profit Margin
84.37%88.45%-4.67%-343.79%-1382.15%
Net Profit Margin
65.51%67.73%1.26%-243.79%-1282.15%
Continuous Operations Profit Margin
65.51%67.73%1.26%-243.79%-1282.15%
Net Income Per EBT
77.64%76.57%-27.06%70.91%92.76%
EBT Per EBIT
125.14%118.93%42.61%96.16%104.03%
Return on Assets (ROA)
45.00%63.35%0.43%-19.46%-36.84%
Return on Equity (ROE)
43.38%76.55%0.44%-19.86%-37.99%
Return on Capital Employed (ROCE)
48.25%84.06%-3.84%-29.12%-39.36%
Return on Invested Capital (ROIC)
37.69%64.37%1.04%-20.65%-36.52%
Return on Tangible Assets
45.00%63.35%0.43%-19.46%-36.84%
Earnings Yield
5.51%4.98%0.02%-1.76%-6.66%
Efficiency Ratios
Receivables Turnover
1.25 16.09 13.36 2.25 0.95
Payables Turnover
22.75 39.63 0.04 0.03 0.04
Inventory Turnover
0.00 0.00 0.00 8.00K >-0.01
Fixed Asset Turnover
6.99K 5.39K 693.00 266.42 71.70
Asset Turnover
0.53 0.94 0.34 0.08 0.03
Working Capital Turnover Ratio
0.76 1.89 0.36 0.10 0.04
Cash Conversion Cycle
-47.20 13.47 -9.39K -11.02K -55.70K
Days of Sales Outstanding
33.93 22.68 27.31 162.58 384.34
Days of Inventory Outstanding
0.00 0.00 0.00 0.05 -45.93K
Days of Payables Outstanding
81.13 9.21 9.42K 11.18K 10.16K
Operating Cycle
33.93 22.68 27.31 162.62 -45.54K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.09 1.46 0.03 -0.08 -0.08
Free Cash Flow Per Share
-0.09 1.45 0.03 -0.08 -0.08
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 0.99 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-1.13K 4.62K 189.42 -997.00 -1.35K
Capital Expenditure Coverage Ratio
-1.13K 4.62K 189.42 -997.00 -1.35K
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
-0.05 0.80 0.25 -3.12 -11.27
Free Cash Flow Yield
5.27%5.86%0.36%-2.25%-5.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
19.10 20.08 5.44K -56.97 -15.02
Price-to-Sales (P/S) Ratio
11.91 13.60 68.81 138.88 192.61
Price-to-Book (P/B) Ratio
7.46 15.37 24.08 11.31 5.71
Price-to-Free Cash Flow (P/FCF) Ratio
-229.01 17.06 279.73 -44.49 -17.08
Price-to-Operating Cash Flow Ratio
-240.73 17.05 278.25 -44.53 -17.10
Price-to-Earnings Growth (PEG) Ratio
1.03 <0.01 -53.22 2.48 0.69
Price-to-Fair Value
7.46 15.37 24.08 11.31 5.71
Enterprise Value Multiple
14.40 15.74 -606.08 -49.51 -12.94
Enterprise Value
2.60B 3.14B 961.25M 407.21M 113.92M
EV to EBITDA
13.99 15.74 -606.08 -49.51 -12.94
EV to Sales
11.79 13.52 66.05 127.37 158.88
EV to Free Cash Flow
18.92 16.97 268.50 -40.80 -14.09
EV to Operating Cash Flow
18.92 16.96 267.09 -40.84 -14.10
Tangible Book Value Per Share
2.78 1.61 0.33 0.33 0.23
Shareholders’ Equity Per Share
2.78 1.61 0.33 0.33 0.23
Tax and Other Ratios
Effective Tax Rate
0.22 0.23 1.27 0.29 0.07
Revenue Per Share
1.66 1.83 0.12 0.03 <0.01
Net Income Per Share
1.09 1.24 <0.01 -0.07 -0.09
Tax Burden
0.78 0.77 -0.27 0.71 0.93
Interest Burden
1.03 1.03 0.42 1.00 1.00
Research & Development to Revenue
0.14 0.12 0.87 2.98 10.83
SG&A to Revenue
0.02 0.03 0.24 0.60 2.46
Stock-Based Compensation to Revenue
<0.01 0.00 0.14 0.26 0.55
Income Quality
0.92 1.18 19.56 1.28 0.88
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis